NASDAQ: CLDX · Health Care / Biotechnology: In Vitro & In Vivo Diagnostic Substances

Celldex Therapeutics Inc.

How Celldex Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.3B

Price

$29.89

P/E

-7.8

EPS (TTM)

$-3.83

1-year return

15.0%

Dividend yield

0.0%

52-week range

$25.07–$32.41

Compared with

• Biotechnology: In Vitro & In Vivo Diagnostic Substances industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources